AN OVERVIEW ON EUDRAGIT BASED NANOPARTICULATE DRUG DELIVERY CARRIERS FOR OCULAR DELIVERY

[1]  E. Denkbaş,et al.  Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[2]  B. Gilger,et al.  Advancements in ocular drug delivery. , 2010, Veterinary ophthalmology.

[3]  Preeti K. Suresh,et al.  Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[4]  A. Mitra,et al.  Novel approaches to retinal drug delivery , 2007, Expert opinion on drug delivery.

[5]  A. Ludwig,et al.  Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. , 2006, International journal of pharmaceutics.

[6]  Francesco Castelli,et al.  Eudragit as controlled release system for anti-inflammatory drugs a comparison between DSC and dialysis experiments , 2003 .

[7]  G. Spedalieri,et al.  Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. , 2002, Biomaterials.

[8]  R. Pignatello,et al.  Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[10]  R. Pignatello,et al.  Flurbiprofen release from eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments , 2008, AAPS PharmSciTech.

[11]  R. Pignatello,et al.  Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. , 2006, AAPS PharmSciTech.